Literature DB >> 3437618

Observations on the development and clinical use of artificial skin--an attempt to employ regeneration rather than scar formation in wound healing.

J F Burke1.   

Abstract

Artificial skin, a bilaminar membrane, is grafted on an excised wound immediately following injury. This bilayer membrane, made of a dermal and epidermal portion, is populated in place on the wound bed by the patient's own fibroblasts and epidermal cells producing a permanent skin replacement with an anatomically functioning dermis and epidermis. The dermal portion is a porous collagen-chondroitin 6-sulfate fibrous matrix arranged in a three dimensional pattern closely resembling the fiber pattern of normal dermis. A thin silastic covering serves as a temporary epidermis immediately after grafting until the patient's epidermal cells, seeded on the "neodermis", grow into a confluent epidermal replacement. The autogenous "neodermis" is produced as fibroblasts and vessels migrate from the wound bed into the artificial dermal template and, using the artificial fibers as a scaffolding, synthesize new connective tissue in the collagen fiber pattern of normal dermis rather than the pattern of scar while slowly biodegrading the artificial fibers. This replacement dermis functions as normal dermis and not as scar tissue. The patient's epidermal cells seeded on the "neodermis" grow into a confluent normal appearing epidermis and with the neodermis produce a permanent skin composed of normal functioning dermal and epidermal components produced in situ by the patient's own cells. Artificial skin has been successfully used to permanently replace skin destroyed by burn injuries ranging from 10 to over 95% BSA. The long-term functional results in these patients have been excellent and the long term cosmetic results in preliminary studies tend to be superior to autograft. Artificial skin appears to provide a successful physiologic and cosmetic skin replacement in severe burn injury.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437618     DOI: 10.1007/BF02470745

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  8 in total

1.  Correlation of in vivo collagen degradation rate with in vitro measurements.

Authors:  I V Yannas; J F Burke; C Huang; P L Gordon
Journal:  J Biomed Mater Res       Date:  1975-11

2.  Primary excision and prompt grafting as routine therapy for the treatment of thermal burns in children.

Authors:  J F Burke; W C Quinby; C C Bondoc
Journal:  Surg Clin North Am       Date:  1976-04       Impact factor: 2.741

3.  Prompt eschar excision: a treatment system contributing to reduced burn mortality. A statistical evaluation of burn care at the Massachusetts General Hospital (1974-1984).

Authors:  R G Tompkins; J F Burke; D A Schoenfeld; C C Bondoc; W C Quinby; G C Behringer; F W Ackroyd
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

4.  Primary burn excision and immediate grafting: a method shortening illness.

Authors:  J F Burke; C C Bondoc; W C Quinby
Journal:  J Trauma       Date:  1974-05

5.  Design of an artificial skin. I. Basic design principles.

Authors:  I V Yannas; J F Burke
Journal:  J Biomed Mater Res       Date:  1980-01

6.  Design of an artificial skin. Part III. Control of pore structure.

Authors:  N Dagalakis; J Flink; P Stasikelis; J F Burke; I V Yannas
Journal:  J Biomed Mater Res       Date:  1980-07

7.  Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury.

Authors:  J F Burke; I V Yannas; W C Quinby; C C Bondoc; W K Jung
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

8.  Design of an artificial skin. II. Control of chemical composition.

Authors:  I V Yannas; J F Burke; P L Gordon; C Huang; R H Rubenstein
Journal:  J Biomed Mater Res       Date:  1980-03
  8 in total
  1 in total

1.  A gelatin/collagen/polycaprolactone scaffold for skin regeneration.

Authors:  Lin-Gwei Wei; Hsin-I Chang; Yiwei Wang; Shan-Hui Hsu; Lien-Guo Dai; Keng-Yen Fu; Niann-Tzyy Dai
Journal:  PeerJ       Date:  2019-02-01       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.